ARVEE

ARVEE LABORATORIES (INDIA)

Small Cap BSE: arvee NSE: ARVEE
₹94.3
2.65 (2.89%)
As on 30 September, 2022 | 01:42

Arvee Laboratories (India) Share Price

Arvee Laboratories (India) Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ARVEE LABORATORIES (INDIA)

Start SIP

Arvee Laboratories (India) Share Returns

  • Over 1 Month 6.31%
  • Over 3 Month 27.41%
  • Over 6 Month -24.63%
  • Over 1 Year 3.73%

Arvee Laboratories (India) Key Statistics

P/E Ratio 40.4
PEG Ratio -10.5
Market Cap Cr 104
Price to Book Ratio 4.3
EPS 2.3
Dividend 0
Relative Strength Index 51.23
Money Flow Index 48.23
MACD Signal 2.49
Average True Range 6.43

Arvee Laboratories (India) Investment Rating

  • Master Rating:
  • Arvee Laboratories (India) has an operating revenue of Rs. 40.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 9% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 4% and 0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Arvee Laboratories (India) Financials
IndicatorMar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1381199
Operating Expenses Qtr Cr 117988
Operating Profit Qtr Cr 21211
Depreciation Qtr Cr 10111
Interest Qtr Cr 00000
Tax Qtr Cr 00000
Net Profit Qtr Cr 11110

Arvee Laboratories (India) Technicals

EMA & SMA

Current Price
91.8
0.15 (0.16%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 91.84
  • 50 Day
  • 89.01
  • 100 Day
  • 88.29
  • 200 Day
  • 91.16
  • 20 Day
  • 91.51
  • 50 Day
  • 87.6
  • 100 Day
  • 85.56
  • 200 Day
  • 91.21

Arvee Laboratories (India) Resistance and Support

PIVOT
₹89.74
Resistance
First Resistance 94.57
Second Resistance 97.49
Third Resistance 102.32
RSI 51.23
MFI 48.23
MACD Single Line 2.5
MACD 1.92
Support
First Resistance 86.82
Second Resistance 81.99
Third Resistance 79.07

Arvee Laboratories (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 523 32,400 61.95
Week 1,207 77,875 64.53
1 Month 1,319 104,188 79.01
6 Month 1,064 95,416 89.68

Arvee Laboratories (India) Result Highlights

Arvee Laboratories (India) Synopsis

NSE-Chemicals-Specialty

Arvee Laboratories belongs to the Industry of Chemicals - Speciality - Others. Company’s Total Operating Revenue is Rs. 40.33 Cr. and Equity Capital is Rs. 11.02 Cr. for the Year ended 31/03/2022. Arvee Laboratories (India) Ltd. is a Public Limited Listed company incorporated on 27/01/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2012PLC068778 and registration number is 068778.
Market Cap 101
Sales 40
Shares in Float 0.29
No of funds
Yield
Book Value 4.22
U/D Vol ratio 1.7
LTDebt / Equity 4
Alpha 0.1
Beta 0.71

Arvee Laboratories (India)

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 73.5%73.5%73.5%
Others 26.5%26.5%26.5%

Arvee Laboratories (India) Management

Name Designation
Mr. Shalin Sudhakarbhai Patel Managing Director
Mr. Shalin Bharat Chokshi Whole Time Director
Mrs. Neetu Rishi Jalan Independent Director
Mr. Dipen Ashit Dalal Independent Director
Mr. Vishal Nitin Mehta Independent Director
Mr. Sachin Kanwarlal Kansal Independent Director

Arvee Laboratories (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Arvee Laboratories (India) Corporate Action

Date Purpose Remarks
2022-05-26 Audited Results
2022-02-08 Quarterly Results
2021-11-12 Quarterly Results
2021-07-17 Quarterly Results
2021-06-17 Audited Results

Arvee Laboratories (India) FAQs

What is Share Price of Arvee Laboratories (India) ?

Arvee Laboratories (India) share price is ₹94 As on 30 September, 2022 | 01:28

What is the Market Cap of Arvee Laboratories (India) ?

The Market Cap of Arvee Laboratories (India) is ₹103.9 Cr As on 30 September, 2022 | 01:28

What is the P/E ratio of Arvee Laboratories (India) ?

The P/E ratio of Arvee Laboratories (India) is 40.4 As on 30 September, 2022 | 01:28

What is the PB ratio of Arvee Laboratories (India) ?

The PB ratio of Arvee Laboratories (India) is 4.3 As on 30 September, 2022 | 01:28

Q1FY23